- Home
- O vs HLN Comparison
O vs HLN Comparison
Compare O & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- O
- HLN
- Stock Information
- Founded
- O 1969
- HLN 2022
- Country
- O United States
- HLN United Kingdom
- Employees
- O N/A
- HLN N/A
- Industry
- O Real Estate Investment Trusts
- HLN Package Goods/Cosmetics
- Sector
- O Real Estate
- HLN Consumer Discretionary
- Exchange
- O Nasdaq
- HLN Nasdaq
- Market Cap
- O 46.0B
- HLN 41.1B
- IPO Year
- O N/A
- HLN N/A
- Fundamental
- Price
- O $54.61
- HLN $9.23
- Analyst Decision
- O Hold
- HLN Strong Buy
- Analyst Count
- O 15
- HLN 2
- Target Price
- O $62.11
- HLN $10.48
- AVG Volume (30 Days)
- O 5.9M
- HLN 9.1M
- Earning Date
- O 02-18-2025
- HLN 02-27-2025
- Dividend Yield
- O 5.75%
- HLN 1.70%
- EPS Growth
- O N/A
- HLN N/A
- EPS
- O 1.04
- HLN 0.18
- Revenue
- O $5,014,703,000.00
- HLN $15,065,004,686.00
- Revenue This Year
- O N/A
- HLN $2.44
- Revenue Next Year
- O $5.93
- HLN $2.43
- P/E Ratio
- O $52.28
- HLN $25.45
- Revenue Growth
- O 28.86
- HLN N/A
- 52 Week Low
- O $50.65
- HLN $7.89
- 52 Week High
- O $64.88
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- O 55.18
- HLN 38.87
- Support Level
- O $51.60
- HLN $8.86
- Resistance Level
- O $53.58
- HLN $9.56
- Average True Range (ATR)
- O 0.90
- HLN 0.12
- MACD
- O 0.39
- HLN -0.03
- Stochastic Oscillator
- O 85.88
- HLN 45.68
About O Realty Income Corporation
Realty Income owns roughly 15,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, gaming, office, manufacturing, and distribution properties, which make up roughly 20% of revenue.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.